The updated ACS guideline adds 3 tests to its recommended screening options, reflecting advances in disease detection and a broader public health effort to expand access and lower barriers to ...
A systematic review was conducted to examine the potential impact of new molecular‐based screening tests on CRC incidence and mortality.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results